Era of COVID-19 in Multiple Sclerosis Care

The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Krett, Jonathan D., Salter, Amber, Newsome, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288315/
https://www.ncbi.nlm.nih.gov/pubmed/37980121
http://dx.doi.org/10.1016/j.ncl.2023.06.006
Descripción
Sumario:The unprecedented scope of the coronavirus disease 2019 (COVID-19) pandemic resulted in numerous disruptions to daily life, including for people with multiple sclerosis (PwMS). In this article, we review how disruptions in MS care prompted innovations in delivery of care (e.g., via telemedicine) and mobilized the global MS community to rapidly adopt safe and effective practices. We discuss how our understanding of the risks of COVID-19 in PwMS has evolved along with recommendations pertaining to disease-modifying therapies (DMTs) and vaccines. With lessons learned during the COVID-19 pandemic, we examine potential questions for future research in this new era of MS care.

Ejemplares similares